NCT00139906View on ClinicalTrials.gov

Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Bifeprunox

Trial Locations (1)

Unknown

Site 1, National City

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

Solvay Pharmaceuticals

INDUSTRY

NCT00139906 - Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia | Biotech Hunter | Biotech Hunter